Equine melanoma in a population of 296 grey Lipizzaner horses.
Authors: Seltenhammer M H, Simhofer H, Scherzer S, Zechner R, Curik I, Sölkner J, Brandt S M, Jansen B, Pehamberger H, Eisenmenger E
Journal: Equine veterinary journal
Summary
# Editorial Summary: Equine Melanoma in Grey Lipizzaner Horses Melanomas represent a significant concern in grey horses, yet their biological behaviour differs markedly from tumours in solid-coloured animals; this Lipizzaner population study sought to quantify disease prevalence and establish the hereditary contribution to melanoma development. Clinical examination and pedigree analysis of 296 grey horses revealed dermal melanomas in exactly half the population (148 horses), with lesions predominantly located beneath the tail (75.6% of cases), whilst heritability estimates indicated a substantial genetic component (h² = 0.36 ± 0.11) despite considerable environmental influence. Notably, despite melanoma progression to stage 4 in some individuals, grey horse melanomas demonstrated significantly lower malignant potential than those in solid-coloured breeds, with tumours frequently presenting as encapsulated nodules or blue naevi-like structures rather than metastasising lesions—a phenomenon potentially attributable to breed-specific genetic suppression of metastatic processes. Age and stud of origin were statistically significant variables (P < 0.0001), together accounting for 28% of disease variability, and affected horses maintained normal performance despite tumour burden. For practitioners, these findings suggest that whilst grey horse melanomas warrant monitoring, their generally indolent nature permits a less aggressive management approach than traditionally applied to equine melanoma; nevertheless, the moderate heritability warrants cautious breeding selection in affected lines, particularly where multiple generations show disease clustering.
Read the full abstract on PubMed
Practical Takeaways
- •Melanomas in grey horses are common (50% prevalence) but rarely cause clinical problems or performance issues, even in advanced stages, unlike melanomas in solid-coloured horses
- •Regular monitoring of grey horses over age 5, particularly under the tail, is recommended for early detection, though malignancy is low and surgical intervention may not always be necessary
- •Genetic predisposition plays a significant role in melanoma development; breeding decisions in grey horse populations should consider family history and stud effects on melanoma occurrence
Key Findings
- •Melanomas were present in 50% (148/296) of grey Lipizzaner horses studied, with 75.6% of melanotic tumours located underneath the tail
- •Heritability estimate of 0.36 (SE 0.11) indicates strong genetic impact on melanoma development in ageing grey horses
- •Stud and age had highly significant effects (P < 0.0001) explaining 28% of variability, with melanomas occurring primarily at age 5 years or more
- •Grey horse melanomas showed less malignancy than solid-coloured horses, with affected individuals often having encapsulated nodules without severe clinical effects or performance handicap